Trial Profile
Phase IIa trial of HF 1020 in patients with mild to moderate allergic asthma.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Sep 2011
Price :
$35
*
At a glance
- Drugs HF 1020 (Primary)
- Indications Allergic asthma
- Focus Therapeutic Use
- 20 Sep 2011 New trial record